Dr. Marcello M. Rotta, MD

Dr. Rotta practices at HealthONE Clinic Services - Oncology Hematology in Denver, Colorado.

Dr. Rotta's NPI, 1700107075, was assigned on June 21, 2010. Dr. Rotta graduated from University of Torino Faculty of Medicine in 2002. Dr. Rotta holds Colorado license 56866.

Dr. Rotta's primary practice is HealthONE Clinic Services - Oncology Hematology, at 1721 E 19th Ave, Denver, CO 80218 in Denver County. The practice phone is (720) 754-4800.

Dr. Rotta's primary practice is HealthONE Clinic Services - Oncology Hematology in Denver, Colorado. Dr. Rotta is also affiliated with HCA HealthONE Presbyterian St. Luke's. The medical group on file is HCA HealthONE Physicians. Dmand AI also links Dr. Rotta to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rotta practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rotta's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Rotta's licenses on file in 4 states: Colorado, New Mexico, Ohio and Washington.

Dmand AI lists chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Rotta treats.

CMS data shows 20,493 Medicare services from Dr. Rotta across 20 procedure codes in 2024, for 239 Medicare patients. Medicare paid $417,910 for them. Every service was in an office.

CMS counts 239 Medicare patients who saw Dr. Rotta in 2024. The largest group is 65 to 74, with 130 patients. 73% of them have high blood pressure, and 67% have high cholesterol. 9% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rotta's median patient age at 66, with 41% women.

In 2024, Dr. Rotta wrote 972 Medicare Part D claims for 81 patients. 61% of them were for generic drugs. CMS names the drug for 675 of them, across 25 drugs with 11 or more claims each, at $4,179,975 in total drug cost. In 2023, CMS named 642 claims across 25 drugs.

Dr. Rotta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rotta as offering telehealth.

Dmand AI links 17 papers to Dr. Rotta, published from 2008 to 2024. 2011 was the busiest year, with 3. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Transplantation Conditioning. Dr. Rotta has published most often in Blood. Dr. Rotta's most frequent co-authors are Benedetto Bruno, MD, Gulrayz Ahmed, MD and Najla Hatem El Jurdi, MD.

Dmand AI links Dr. Rotta to 5 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Myelodysplastic Syndromes and Multiple Myeloma. Washington University School of Medicine sponsors the most, 2.

CMS Open Payments shows 233 general payments to Dr. Rotta from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Jazz Pharmaceuticals Inc. paid the most, $46,460. It also lists 1 research payment totaling $330 in 2024.

Dr. Rotta graduated from University of Torino Faculty of Medicine in 2002.

Dr. Rotta is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.